Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies
about
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeLevosimendan: current data, clinical use and future developmentTargeting the sarcomere to correct muscle functionStructure and function of cardiac troponin C (TNNC1): Implications for heart failure, cardiomyopathies, and troponin modulating drugsAdvanced heart failure: an appraisal of the potential of levosimendan in this end-stage scenario and some related ethical considerations.Early administration of levosimendan is associated with improved kidney function after cardiac surgery - a retrospective analysis.Levosimendan Relaxes Pulmonary Arteries and Veins in Precision-Cut Lung Slices - The Role of KATP-Channels, cAMP and cGMP.De novo acute heart failure and acutely decompensated chronic heart failureMajor themes for 2011 in cardiovascular anesthesia and intensive careLevosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).Diagnosis and management of acute heart failureCauses and treatment of oedema in patients with heart failure.The use of levosimendan in children with cancer with severe acute cardiac dysfunction: case series and a review of the literature.Cardiorenal syndrome: new developments in the understanding and pharmacologic management.Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis.Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.Levosimendan in acute and advanced heart failure: an appraisal of the clinical database and evaluation of its therapeutic applications.Role of PiCCO monitoring for the integrated management of neurogenic pulmonary edema following traumatic brain injury: A case report and literature review.Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan.Levosimendan improves exercise performance in patients with advanced chronic heart failure.Can a meta-analysis that mixes apples with oranges be used to demonstrate that levosimendan reduces mortality after coronary revascularization?Prevention of organ dysfunction in septic shock: still looking for an effective treatment.Basics of cardiopulmonary bypass.Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.eComment. Levosimendan in adult patients undergoing cardiac surgery.Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery.Levosimendan in advanced heart failure: where do we stand?The clinical effects of levosimendan are not attenuated by sulfonylureas.Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice.Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial.Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta-analysis of randomized trials.Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?[Pilot study of levosimendan : Effect on liver blood flow and liver function in acute decompensated heart failure].Preoperative levosimendan in ischemic mitral valve repair.Levosimendan in patients with low ejection fraction undergoing cardiac surgery.
P2860
Q24201225-FA387161-99F4-4B7B-AD01-A52059B1B805Q24629274-94A7D3C7-8F11-4685-8D96-A19E06E5A203Q28260629-0DB7F511-B94B-45BB-8FB4-94BF14B25311Q28607749-D14C8D0E-3B8F-4E8C-B853-5CF8D42C6371Q30394479-81701DD0-060C-4258-B47A-2F3135B06A24Q34558248-481D2797-6FE5-4706-A94E-8BEB9C295C43Q34793581-08CAD034-6585-4234-9AA7-CE8C99B0D12DQ35675983-2CEFF3EB-9826-43DA-B83F-4D48C42E8067Q36359465-8017C234-C44C-44C1-A309-6E9497117A92Q36832816-3BB204EB-201C-4FB5-B8E9-057B7FEB2719Q37154191-D4F572F0-9E07-4F85-9A53-E55C2BD3E501Q37680530-3E2CA7AB-0340-4CF1-9E32-0B86CEB5876CQ38074093-18046AB6-40E0-46C3-94CF-885C282F81EEQ38105336-0E80BF71-047B-4A9D-80AC-EDAAD6A9811FQ38127668-BABE4BB8-9974-4B89-8610-DD1A827D4B9EQ38173852-599A8901-302C-4991-8F38-0DAD16CCE45FQ38292123-59481998-5D20-448A-917A-AFD7E828AF2DQ38372545-57AF54E3-12C2-4915-A3D9-4195482C4E17Q38620002-DE0E533C-B851-4C5D-BE57-61D0697E8721Q38971428-EDB0D4B6-7CE0-480B-8556-CCC781BA70D8Q40667028-8305704C-361D-414D-982D-D2A36026F78BQ40964343-845500BD-8315-464C-9E41-FFC6B294443BQ41226308-A1EB759A-B383-4F7A-93A1-419D7708F491Q42003837-0FB49C92-C5CA-4B14-A9E5-1725A287AAE0Q42331443-DB344158-E051-480E-ABCF-1D4A6C4E428AQ42363993-B206D13C-305F-4991-AFEF-31CDBCDAA40EQ42653967-64FA15F8-BBC5-4D58-9BFB-57D003378E9AQ42970093-1FDCDD50-72C7-4951-8EF9-1ADACD194793Q43686339-7B7E3D01-8A17-49E1-8EBF-8C712B2FBF9DQ45068518-98C815DB-760E-405A-9284-FC47FF7B748FQ47212291-D9C84D76-7EB6-460B-B19C-B9C64C07EA77Q47237484-2173F3B0-9912-4784-A15F-61AB431151DDQ47877301-D711E0F3-F092-4135-ACC7-FCC255241274Q48073496-25FFAAB1-F170-4EFE-89FD-F1FAA3829F4FQ48187672-B7301993-1B5F-47E1-82B6-7141C5A39FF8Q48263954-E4708BC3-10F6-4422-8819-4786944EA33FQ48283568-CB4F75E9-FA3A-413B-9CBF-386550DB6F7BQ50457479-726F783B-0C02-4A71-877C-96D644802D94Q51721222-409E18F4-9560-4D1E-AF81-1497FFC3E5D0Q52571368-93CB330C-65BD-424E-822D-02700A1EDF21
P2860
Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effects of levosimendan on mor ...... randomized controlled studies
@ast
Effects of levosimendan on mor ...... randomized controlled studies
@en
Effects of levosimendan on mor ...... randomized controlled studies
@nl
type
label
Effects of levosimendan on mor ...... randomized controlled studies
@ast
Effects of levosimendan on mor ...... randomized controlled studies
@en
Effects of levosimendan on mor ...... randomized controlled studies
@nl
prefLabel
Effects of levosimendan on mor ...... randomized controlled studies
@ast
Effects of levosimendan on mor ...... randomized controlled studies
@en
Effects of levosimendan on mor ...... randomized controlled studies
@nl
P2093
P50
P3181
P1476
Effects of levosimendan on mor ...... randomized controlled studies
@en
P2093
Elena Bignami
Giovanni Landoni
Teresa Greco
P304
P3181
P356
10.1097/CCM.0B013E318232962A
P407
P577
2012-02-01T00:00:00Z